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Abstract
This review summarizes the findings and importance of 12 articles from research at Columbia
University in New York City that were among the most cited in the literature between 2006 and
2011. The 12 articles summarized in this review made important contributions to the field of
Alzheimer’s disease in the last 5 years. Four of the articles established the Mediterranean diet as a
food consumption pattern that may prevent Alzheimer’s disease in addition to physical activity.
Two of the articles advanced our knowledge of predictors of conversion from mild cognitive
impairment to dementia. Four of the articles provided important knowledge of risk factors for the
progression of Alzheimer’s disease and its complications. Lastly, one of the articles laid the
theoretical framework for the study of cognitive reserve, an important modifier of the
manifestation of Alzheimer’s disease. These studies have advanced our knowledge about risk
factors, modifiers, and progression of late onset Alzheimer’s disease.
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This review summarizes the findings and importance of 12 articles [1–12] from research at
Columbia University in New York City that were among the most cited in the literature
between 2006 and 2011. The determination of citations was made using the Thomson
Reuters Bibliometric analysis tool called HistCite by Aaron Sorensen, Editor of the Journal
of Alzheimer’s Disease.
These studies come from three different cohorts based at Columbia University Medical
Center in New York City. These cohorts are:
• The Washington Heights-Inwood Columbia Aging Project (WHICAP; PI: Richard
Mayeux) is comprised of two related community-based cohorts, one recruited from
1992 to 1994 [13], and one recruited from 1999 to 2001 [14]. Subjects in WHICAP
were 65 years and older at the time of recruitment, were enrolled in Medicare, and
were from three ethnic groups: Hispanics, non-Hispanic Blacks, and non-Hispanic
Whites. The main goal of WHICAP is to study the epidemiology and predictors of
cognitive disorders in an urban multiethnic cohort.
• The Predictors Study (PI: Yaakov Stern) is a community based cohort study of
persons with a diagnosis of Alzheimer’s disease (AD) followed prospectively. The
main goal of the predictors study is to characterize the progression of AD and
identify modifiers of progression.
• The Questionable Dementia 1 study (QD1; PI: Devangere Devanand), a cohort
study of persons with a diagnosis of mild cognitive impairment (MCI), recruited
from a referral memory disorders clinic. The goal of the QD1 study is to identify
predictors of progression to dementia among persons with MCI.
Among the 12 most cited articles that resulted from these studies, four reported on
modifiable risk factors for AD [1–4], one reported on genetic risk factors for AD [10], two
reported on predictors of conversion of MCI to AD [7, 9], four reported on progression of
AD [5, 6, 11, 12], and one was a review article on an important modifier of AD risk,
cognitive reserve [8]. This article is organized following these themes. We provide
summaries of each article, put the findings in perspective, and briefly discuss their
importance to the field.
STUDIES OF NON-GENETIC RISK FACTORS FOR LATE ONSET
ALZHEIMER’S DISEASE
Four of the 12 studies examined the relationship of putative risk factors with incident AD
[1–4]. These studies are summarized in Table 1. These studies were conducted in WHICAP.
All of the studies examined diet, and more specifically, adherence to the Mediterranean diet,
in relation to incident AD or MCI. One of the studies also examined physical activity in
addition to diet [4]. One of the studies examined the role of vascular mediation in the
relationship of the Mediterranean diet with AD [4]. In summary, these studies found that
higher adherence to a Mediterranean diet was related to a lower risk of MCI and AD, that
these relationships were not explained by vascular mediation, and were stronger when
accompanied with higher physical activity. In relation to the lack of mediation by vascular
disease, it is likely that this finding was explained by the lack of sensitivity of medical
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history and blood markers as surrogates for cerebrovascular disease. We later found that
cerebrovascular disease ascertained on brain imaging did suggest a vascular mediation in
this relationship [15].
This compendium of articles is important for several reasons. First, no modifiable risk
factors for AD have been identified thus far despite intensive research [16], and these studies
demonstrate that lifestyle factors with available evidence for benefits for cardiovascular
disease can also help AD potentially through non-vascular mechanisms. Second, the study
of diet and AD had traditionally been limited to the study of specific nutrients (e.g.,
vitamins) rather than food consumption patterns. Our studies were the first to examine how
an established measurable food consumption pattern, the Mediterranean diet, could reduce
the risk of AD. Third, one of the studies demonstrated that adhering to two available healthy
life-style choices, the Mediterranean diet and physical activity, could jointly decrease the
risk of AD. It is important to point out that these studies carefully accounted for confounders
such as caloric intake and low education. Thus, we do not believe that these important
findings are explained by confounding factors.
STUDIES OF GENETIC RISK FACTORS FOR LATE ONSET ALZHEIMER’S
DISEASE
One of the 12 studies examined the relationship of a novel genetic risk factor, SORL1, with
AD [10]. Variants in 3′ and 5′ regions of SORL1, the neuronal sorting protein-related
receptor, have been found to be associated with late onset familial and sporadic AD in
several datasets that were selected for familial aggregation or were ethnically diverse or
clinic-based selected series. Our nested case-control study was performed using the
community-based WHICAP study. There were 296 patients with probable AD and 428
healthy elderly controls. The participants were of African American (34%), Caribbean
Hispanic (51%), or non-Hispanic whites (15%). Several individual single-nucleotide
polymorphisms (SNPs) and SNP haplotypes were significantly associated with AD in this
prospectively collected community-based cohort, confirming the previously reported
positive association of SORL1 with AD. SNP 12 near the 5′ region was associated with AD
in African-Americans and Hispanics. Two SNPs in the 3′ region were also associated with
AD in African-Americans (SNP 26) and whites (SNP 20). A single haplotype C-C-A at
SNPs 4–6 was associated with AD in Hispanics. However, several different haplotypes were
associated with AD in the African-Americans and whites, including the haplotype T-T-C at
SNPs 23–25 (p = 0.035) that was significantly associated with AD in the North European
whites in a previous report.
The contributions of this article to the field included the confirmation of the association
between AD and variants in the SORL1 gene in a population based multiethnic cohort. Also,
the discovery of significant association in multiple regions of the gene, and the discovery of
different AD-associated haplotypes different from those in other studies revealed that there
may be a high degree of allelic heterogeneity, with disease-associated variants occurring on
multiple different haplotypic backgrounds. Thus, second attempts to identify the pathogenic
variants in SORL1 will likely have to investigate larger regions of the SORL1 gene than
simply just between SNPs 8–10 and 22–25. This study is part of a larger effort in genetic
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epidemiology research in which our group participates that has established SORL-1 as one
the most important genetic risk factors for AD [17–21] after APOE-ε4. Late onset AD is
increasing recognized as a complex heterogeneous condition in which multiple pathways
and factors are likely to be involved. The discovery of new genetic factors in late onset AD,
in this case SORL-1, is providing new insights into these pathways.
STUDIES OF CONVERSION FROM MILD COGNITIVE IMPAIRMENT TO
ALZHEIMER’S DISEASE
Two of the 12 articles [7, 9] (Table 2) summarized in this review reported
neuropsychological and imaging predictors of conversion from non-dementia cognitive
impairment to AD in the QD1 study. QD1 was a cohort based in a memory disorders clinic,
as compared with the studies of non-genetic and genetic risk factors previously described,
which were community-based.
The first article [7] evaluated conversion rates to AD in subtypes of MCI and identified
neuropsychological measures most predictive of the time to conversion. This study
demonstrated that mildly cognitively impaired patients with memory plus other cognitive
domain deficits, rather than those with pure amnestic MCI, constituted the high risk group
for conversion. Deficits in verbal memory and psychomotor speed/executive function
abilities strongly predicted conversion to AD. This study raised the intriguing possibility that
these amnestic “plus” patients constitute a group at high risk for conversion to AD, whereas
the pure amnestic MCI patients may not be at such a high risk. However, with longer
follow-up, the pure amnestic MCI patients may develop multiple cognitive domain deficits
and eventually convert to AD. These findings also suggest that testing for deficits in
multiple cognitive domains in addition to those in memory improves the predictive value of
neuropsychological testing in patients with MCI. The study showed that combining
commonly used neuropsychological tests strongly predicted conversion from MCI to AD,
emphasizing the critical role of cognitive testing in evaluation and prediction of outcome in
patients with MCI.
The second article [9] evaluated the utility of magnetic resonance imaging (MRI)
hippocampal and entorhinal cortex size in predicting conversion from MCI to AD.
Hippocampal and entorhinal cortex volumes were each largest in controls, intermediate in
MCI non-converters, and smallest in MCI converters to AD. Smaller hippocampal volume
and entorhinal cortex volume each predicted time to conversion to AD. Similar results were
obtained for hippocampal and entorhinal cortex volume in patients with MCI with Mini-
Mental State Exam (MMSE) scores ≥27/30 (21% converted to AD) and in the subset of
patients with amnestic MCI (35% converted to AD). In the total patient sample, when both
hippocampal and entorhinal volume were entered into an age-stratified Cox model with
gender, MMSE, education, and intracranial volume, smaller hippocampal volume and
entorhinal cortex volume predicted time to conversion to AD. Similar results were obtained
in a Cox model that also included neuropsychological test scores. Based on logistic
regression models in the 3-year follow-up sample, for a fixed specificity of 80%, the
addition of hippocampal and entorhinal cortex volumes to demographic and
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neuropsychological variables markedly improved the sensitivity of a predictive model for
conversion to AD to well over 80%.
At the time that these two studies were published, they were the largest studies testing the
predictors of conversion from MCI to AD. The study of neuropsychological predictors
demonstrated that persons with amnestic MCI and involvement with other cognitive
domains represented a higher risk group for conversion than those with pure amnestic MCI.
The imaging study demonstrated that hippocampal and entorrinal cortex size add
information to the neuropsychological data in predicting conversion from MCI to dementia.
The importance of these studies in the field is that it helps clinicians identify persons with
MCI at high risk for conversion. This group perhaps should be targeted for interventions.
STUDIES OF PROGRESSION IN ALZHEIMER’S DISEASE
Four of the 12 studies examined the predictors of progression and consequences of AD [6,
11, 12] (Table 3). Compared to the previous categories of studies, these studies were
conducted in a cohort of persons with AD from Northern Manhattan followed prospectively.
One study examined the association of years of education on AD progression and found that
higher years of education were related to steeper cognitive decline [5]. Another study
examined the association of vascular risk factors status before AD diagnosis with rate of
cognitive decline and found that higher total cholesterol, low-density-lipoprotein cholesterol,
and diabetes were associated with faster cognitive decline [6]. One study examined the
association of Mediterranean diet adherence before AD diagnosis with mortality among
persons with AD [12] and found that persons with higher Mediterranean diet adherence had
lower mortality. Lastly, one study found that the incidence of seizures was higher than
expected in persons with AD and that younger individuals, African Americans, and those
with more severe disease or a focal epileptiform findings on EEG were more likely to have
unprovoked seizures [12].
These studies are important because the prevalence of AD will continue to increase in the
absence of established methods for prevention and cure, and because studying disease
progression in AD provides insights about its mechanisms. The studies examining the roles
of diet and vascular risk factors established that these exposures not only potentially affect
the risk of AD but also its course and mortality. The study examining seizures shows
clinicians following persons with AD that they should expect the need to treat seizures and
provided potential predictors for this complication. The study on education and AD course
provides important support for the cognitive reserve hypothesis that is discussed next.
COGNITIVE RESERVE AND ALZHEIMER’S DISEASE
This article was the only one out of the 12 to review a topic in AD [8] suggesting a
framework for the study of an important hypothesized modifier of its clinical presentation.
Epidemiologic evidence suggests that individuals with higher intelligence quotient,
education, occupational attainment, or participation in leisure activities have a reduced risk
of developing AD. The concept of cognitive reserve posits that individual differences in how
tasks are processed provide differential reserve against brain pathology or age-related
changes. This may take two forms, neural reserve and neural compensation. In neural
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reserve, pre-existing brain networks that are more efficient or have greater capacity may be
less susceptible to disruption. In neural compensation, alternate networks may compensate
for pathology’s disruption of pre-existing networks. Imaging studies have begun to identify
the neural substrate of cognitive reserve. Because cognitive reserve may modulate the
clinical expression of AD pathology, it is an important consideration in studies of
“preclinical” AD and treatment studies. There is also the possibility that directly enhancing
cognitive reserve may help forestall the diagnosis of AD.
The AD field is at a juncture in which there is growing acceptance that this disease is more
heterogeneous than originally thought and there is uncertainty about the validity of the
hypothesis that postulates that brain amyloid deposition is the main culprit. Other aspects
such as vascular disease are increasingly recognized as contributors to AD, but even this
element has proven insufficient to explain AD risk. In this context, the concept of cognitive
reserve has emerged as an important modifier of disease expression that requires further
study. Research is needed to better characterize the measurement of this concept and to
understand how it affects AD risk. For example, a sensitive measure of cognitive reserve
could help the assessment of its modulation of risk factors such as the Mediterranean diet,
could improve predictive models for conversion from MCI to AD, and could help better
predict to progression of AD.
SUMMARY
The 12 articles summarized in this review made important contributions to the field of AD
in the last 5 years. Four of the articles established the Mediterranean diet as a food
consumption pattern that may prevent AD in addition to physical activity. Two of the
articles advanced our knowledge of predictors of conversion from MCI to dementia. Four of
the articles provided important knowledge of risk factors for the progression of AD and its
complications. Lastly, one of the articles laid the theoretical framework for the study of
cognitive reserve, an important modifier of the manifestation of AD.
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Table 3
Summary of most cited articles reporting on the progression of late onset Alzheimer’s disease. The studies are
based in a cohort of persons with late onset Alzheimer’s disease in New York City (PI: Y. Stern)
Study [Ref] Participants/design Exposures/outcomes Findings
N Scarmeas, SM







During the course of a
community-based
multiethnic prospective
cohort study of individuals
aged ≥65 years living in
New York, 312 patients
were diagnosed with
incident AD and were
followed overall for 5.6
(up to 13.3) years
The subjects received an average of
3.7 (up to 9) neuropsychological
assessments consisting of 12
individual tests. With the aid of a
normative sample, a standardized
composite cognitive score, as well
as individual cognitive domain
scores were calculated. GEE models
were used to examine the
association between education and
rates of cognitive decline
Composite cognitive performance declined by
9% of a standard deviation per year. Rates of
decline before and after AD incidence were
similar. For each additional year of education
there was 0.3% standard deviation lower
composite cognitive performance for each year
of follow-up. The association between higher
education and faster decline was noted
primarily in the executive-speed (0.6%) and
memory (0.5%) cognitive domains and was
present over and above age, gender, ethnicity,
differential baseline cognitive performance,








A total of 192 community-
based individuals in New




Adherence to the MeDi (0–9 point
scale with higher scores indicating
higher adherence) was the main
predictor of mortality in Cox models
that were adjusted for period of
recruitment, age, gender, ethnicity,
education, APOE genotype, caloric
intake, smoking, and BMI
85 AD patients (44%) died during the course of
4.4 (±3.6, 0.2–13.6) years of follow-up. In
unadjusted models, higher adherence to MeDi
was associated with lower mortality risk (for
each additional MeDi point HR 0.79; 95% CI
0.69–0.91; p = 0.001). This result remained
significant after controlling for all covariates
(0.76; [0.65–0.89]; p = 0.001). In adjusted
models, as compared to AD patients at the
lowest MeDi adherence tertile, those at the
middle tertile had lower mortality risk (0.65;
[0.38–1.09]; 1.33 years longer survival), while
subjects at the highest tertile had an even lower
risk (0.27 [0.10–0.69]; 3.91 years longer





Jacobs, K Marder, K







Mild AD patients were
prospectively followed at
6-month intervals
Estimate incidence of unprovoked
seizures, compare age-specific risk
of unprovoked seizures with
population norms, and identify
characteristics at baseline
(demographics, duration and
severity of AD, physical and
diagnostic test findings, and
comorbid medical and psychiatric
conditions) influencing unprovoked
seizure risk. Review of study charts
and medical records supplemented
coded end-point data
The cumulative incidence of unprovoked
seizures at 7 years was nearly 8%. In all age
groups, risk was increased compared with a
standard population, with an 87-fold increase in
the youngest group (age 50–59 years) and more
than a threefold increase in the oldest group
(age 85 + years). In multivariate modeling,
independent predictors of unprovoked seizures
were younger age (RR, 0.89 per year increase in
age; 95% CI, 0.82–0.97), African-American
ethnic background (RR, 7.35; 95% CI, 1.42–
37.98), more-severe dementia (RR, 4.15; 95%
CI, 1.06–16.27), and focal epileptiform findings













156 incident AD patients




The exposures were vascular factors
including medical history (heart
disease, stroke, diabetes,
hypertension), smoking, and pre-
diagnosis blood lipid measurements
(total cholesterol, HDL-C, LDL-C,
and triglycerides). The main
outcome was change in a composite
score of cognitive ability from
diagnosis on
In GEE models (adjusted for age, race/ethnicity
and education), higher cholesterol (total and
LDL-C), and diabetes history were associated
with faster cognitive decline. Each 10-unit
increase in cholesterol and LDL-C was
associated with a 10% of a standard deviation
decrease in cognitive score per year of follow-
up (p < 0.001 for total cholesterol, p = 0.001 for
LDL-C). HDL and triglycerides were not
associated with rate of decline. Diabetes history
was associated with an additional 50% of a
standard deviation decrease in cognitive score
per year (p = 0.05). History of heart disease and
stroke were associated with cognitive decline
among APOE ε4 carriers only. In a final GEE
model that included HDL-C, LDL-C, and
diabetes, only higher LDL-C was independently
associated with faster cognitive decline
AD, Alzheimer’s disease; APOE, apolipoprotein E; BMI, body mass index; GEE, general estimating equation; HDL-C, high density lipoproteins;
HR, hazards ratio; LDL-C, low density lipoproteins; MeDi, Mediterranean diet; RR, risk ratio.
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